Klepetko, Walter

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

Galiè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., et al. (2016) · European Heart Journal

Pulmonary Hypertension Research and TreatmentsVascular Anomalies and Treatments

Cited by 6,931

The European IPF registry (eurIPFreg): baseline characteristics and survival of patients with idiopathic pulmonary fibrosis

Guenther, A., Krauss, E., Tello, S., Wagner, J., Paul, B., Kuhn, S., Maurer, O., Heinemann, S., Costabel, U., Barbero, M. A. N., et al. (2018) · Respiratory Research

Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisChronic Obstructive Pulmonary Disease (COPD) Research

Cited by 268

Intraoperative extracorporeal membrane oxygenation and the possibility of postoperative prolongation improve survival in bilateral lung transplantation

Hoetzenecker, K., Schwarz, S., Muckenhuber, M., Benazzo, A., Frommlet, F., Schweiger, T., Bata, O., Jaksch, P., Ahmadi, N., Muraközy, G., et al. (2018) · The Journal of Thoracic and Cardiovascular Surgery

Transplantation: Methods and OutcomesMechanical Circulatory Support Devices

Cited by 242

Intensive care, right ventricular support and lung transplantation in patients with pulmonary hypertension

Hoeper, M. M., Benza, R. L., Corris, P., de Perrot, M., Fadel, E., Keogh, A. M., Kühn, C., Savale, L., & Klepetko, W. (2019) · European Respiratory Journal

Pulmonary Hypertension Research and TreatmentsTransplantation: Methods and Outcomes

Cited by 216

Bilateral lung transplantation on intraoperative extracorporeal membrane oxygenator: an observational study

Hoetzenecker, K., Benazzo, A., Stork, T., Sinn, K., Schwarz, S., Schweiger, T., Klepetko, W., Kifjak, D., Baron, D. M., Hager, H., et al. (2020) · The Journal of Thoracic and Cardiovascular Surgery

Transplantation: Methods and OutcomesMechanical Circulatory Support Devices

Cited by 157

Tacrolimus and cyclosporine have differential effects on the risk of development of bronchiolitis obliterans syndrome: Results of a prospective, randomized international trial in lung transplantation

Treede, H., Glanville, A. R., Klepetko, W., Aboyoun, C., Vettorazzi, E., Lama, R., Bravo, C., Knoop, C., Aubert, J.-D., & Reichenspurner, H. (2012) · The Journal of Heart and Lung Transplantation

Transplantation: Methods and OutcomesRenal Transplantation Outcomes and Treatments

Cited by 130

Twenty-year experience with extracorporeal life support as bridge to lung transplantation

Benazzo, A., Schwarz, S., Frommlet, F., Schweiger, T., Jaksch, P., Schellongowski, P., Staudinger, T., Klepetko, W., Lang, G., Hoetzenecker, K., et al. (2019) · The Journal of Thoracic and Cardiovascular Surgery

Transplantation: Methods and OutcomesMechanical Circulatory Support Devices

Cited by 126

Current therapy of KRAS-mutant lung cancer

Ghimessy, A., Radeczky, P., Laszlo, V., Hegedus, B., Renyi-Vamos, F., Fillinger, J., Klepetko, W., Lang, C., Dome, B., & Megyesfalvi, Z. (2020) · Cancer and Metastasis Reviews

Lung Cancer Treatments and MutationsProtein Kinase Regulation and GTPase Signaling

Cited by 115

Tacrolimus versus cyclosporine after lung transplantation: a prospective, open, randomized two-center trial comparing two different immunosuppressive protocols

Treede, H., Klepetko, W., Reichenspurner, H., Zuckermann, A., Meiser, B., Birsan, T., Wisser, W., & Reichert, B. (2001) · The Journal of Heart and Lung Transplantation

Transplantation: Methods and OutcomesRenal Transplantation Outcomes and Treatments

Cited by 108

Limited Tumor Tissue Drug Penetration Contributes to Primary Resistance against Angiogenesis Inhibitors

Torok, S., Rezeli, M., Kelemen, O., Vegvari, A., Watanabe, K., Sugihara, Y., Tisza, A., Marton, T., Kovacs, I., Tovari, J., et al. (2017) · Theranostics

Angiogenesis and VEGF in CancerMass Spectrometry Techniques and Applications

Cited by 70

Treprostinil inhibits proliferation and extracellular matrix deposition by fibroblasts through cAMP activation

Lambers, C., Roth, M., Jaksch, P., Muraközy, G., Tamm, M., Klepetko, W., Ghanim, B., & Zhao, F. (2018) · Scientific Reports

Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisPulmonary Hypertension Research and Treatments

Cited by 61

KRAS Mutations Predict Response and Outcome in Advanced Lung Adenocarcinoma Patients Receiving First-Line Bevacizumab and Platinum-Based Chemotherapy

Ghimessy, Á. K., Gellert, Á., Schlegl, E., Hegedus, B., Raso, E., Barbai, T., Timar, J., Ostoros, G., Megyesfalvi, Z., Gieszer, B., et al. (2019) · Cancers

Lung Cancer Treatments and MutationsLung Cancer Diagnosis and Treatment

Cited by 27

Circulating Activin A Is a Novel Prognostic Biomarker in Malignant Pleural Mesothelioma—A Multi-Institutional Study

Hoda, M. A., Dong, Y., Rozsas, A., Klikovits, T., Laszlo, V., Ghanim, B., Stockhammer, P., Ozsvar, J., Jakopovic, M., Samarzija, M., et al. (2016) · European Journal of Cancer

Occupational and environmental lung diseasesTGF-β signaling in diseases

Cited by 27